- Home
- TVTX vs NABL Comparison
TVTX vs NABL Comparison
Compare TVTX & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- NABL
- Stock Information
- Founded
- TVTX 2008
- NABL 2000
- Country
- TVTX United States
- NABL United States
- Employees
- TVTX N/A
- NABL N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- NABL Computer Software: Prepackaged Software
- Sector
- TVTX Health Care
- NABL Technology
- Exchange
- TVTX Nasdaq
- NABL Nasdaq
- Market Cap
- TVTX 1.4B
- NABL 1.2B
- IPO Year
- TVTX N/A
- NABL N/A
- Fundamental
- Price
- TVTX $16.48
- NABL $7.80
- Analyst Decision
- TVTX Strong Buy
- NABL Buy
- Analyst Count
- TVTX 16
- NABL 4
- Target Price
- TVTX $33.33
- NABL $9.38
- AVG Volume (30 Days)
- TVTX 1.6M
- NABL 1.1M
- Earning Date
- TVTX 07-31-2025
- NABL 08-07-2025
- Dividend Yield
- TVTX N/A
- NABL N/A
- EPS Growth
- TVTX N/A
- NABL N/A
- EPS
- TVTX N/A
- NABL 0.08
- Revenue
- TVTX $273,533,000.00
- NABL $470,595,000.00
- Revenue This Year
- TVTX $73.84
- NABL $8.35
- Revenue Next Year
- TVTX $46.72
- NABL $8.84
- P/E Ratio
- TVTX N/A
- NABL $96.02
- Revenue Growth
- TVTX 75.65
- NABL 7.98
- 52 Week Low
- TVTX $7.93
- NABL $6.07
- 52 Week High
- TVTX $25.29
- NABL $15.00
- Technical
- Relative Strength Index (RSI)
- TVTX 59.73
- NABL 46.80
- Support Level
- TVTX $14.44
- NABL $8.15
- Resistance Level
- TVTX $16.64
- NABL $8.45
- Average True Range (ATR)
- TVTX 0.61
- NABL 0.22
- MACD
- TVTX 0.31
- NABL -0.00
- Stochastic Oscillator
- TVTX 94.18
- NABL 46.45
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.